Published in Cancer Weekly, March 24th, 1997
The company and the NCI have been in the process of structuring a Cooperative Research and Development Agreement (CRADA) in which the NCI intends to sponsor multiple clinical trials evaluating Gd-Tex, a radiation sensitizer (also shown to be potentially useful as a chemosensitizer), and Lu-Tex, a photosensitizer, in several types of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.